Comparison of human papillomavirus detection and typing by Hybrid Capture 2, Linear array, DNA chip, and cycle sequencing in cervical swab samples

Jae Kwan Lee, Mi Kyung Kim, Seung Hun Song, Jin Hwa Hong, Kyung Jin Min, Jae-Hoon Kim, Eun Seop Song, Jungpil Lee, Jong Min Lee, Soo Young Hur

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Although the Hybrid Capture II (HC II) assay can detect 13 high-risk human papillomavirus (HPVs), it does not yield any genotype-specific information. We evaluated the performance of 4 HPV DNA tests, namely, HC II, Linear Array (LA), DNA chip, and cycle sequencing for their capacity to detect the presence of high-risk HPV DNA and HPV-associated cervical lesions. Seventy-six women who were referred to the colposcopy clinic for abnormal cytology were enrolled. The women were examined using liquid-based cytology, colposcopy-directed biopsy, and HPV DNA tests. After DNA extraction from a single sample, HPV DNA tests were performed by all 4 methods on the same specimen. The LA test has higher HPV-positive rates than HC II for cervical intraepithelial neoplasia I (83.3% vs 61.1%; P < 0.01) and for cervical intraepithelial neoplasia II and more severe lesions (100.0% vs 80.0%; P < 0.01). The concordance between the DNA chip and LA tests was 89.5%, confirming substantial agreement (κ coefficient = 0.73), and the concordance between HC II and the DNA chip was 80.3%, also showing substantial agreement (κ coefficient = 0.738). The concordance for 15 high-risk HPV genotypes between LA and sequencing was 82.5% with a κ value of 0.536. Furthermore, the LA test was more sensitive in the detection of high-grade cervical lesions than HC II (100% vs 92.3%, P < 0.01). The LA test showed superior sensitivity in the detection of clinically relevant HPV infections and has proven to be an accurate tool for identifying individual HPV types, especially in cases of multiple HPV infections.

Original languageEnglish
Pages (from-to)266-272
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume19
Issue number2
DOIs
Publication statusPublished - 2009 Feb 1

Fingerprint

Oligonucleotide Array Sequence Analysis
Human Papillomavirus DNA Tests
Colposcopy
Cervical Intraepithelial Neoplasia
Papillomavirus Infections
Cell Biology
Genotype
DNA
Biopsy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Lee, Jae Kwan ; Kim, Mi Kyung ; Song, Seung Hun ; Hong, Jin Hwa ; Min, Kyung Jin ; Kim, Jae-Hoon ; Song, Eun Seop ; Lee, Jungpil ; Lee, Jong Min ; Hur, Soo Young. / Comparison of human papillomavirus detection and typing by Hybrid Capture 2, Linear array, DNA chip, and cycle sequencing in cervical swab samples. In: International Journal of Gynecological Cancer. 2009 ; Vol. 19, No. 2. pp. 266-272.
@article{74812a773f144dfe84f4fb638c45a5e4,
title = "Comparison of human papillomavirus detection and typing by Hybrid Capture 2, Linear array, DNA chip, and cycle sequencing in cervical swab samples",
abstract = "Although the Hybrid Capture II (HC II) assay can detect 13 high-risk human papillomavirus (HPVs), it does not yield any genotype-specific information. We evaluated the performance of 4 HPV DNA tests, namely, HC II, Linear Array (LA), DNA chip, and cycle sequencing for their capacity to detect the presence of high-risk HPV DNA and HPV-associated cervical lesions. Seventy-six women who were referred to the colposcopy clinic for abnormal cytology were enrolled. The women were examined using liquid-based cytology, colposcopy-directed biopsy, and HPV DNA tests. After DNA extraction from a single sample, HPV DNA tests were performed by all 4 methods on the same specimen. The LA test has higher HPV-positive rates than HC II for cervical intraepithelial neoplasia I (83.3{\%} vs 61.1{\%}; P < 0.01) and for cervical intraepithelial neoplasia II and more severe lesions (100.0{\%} vs 80.0{\%}; P < 0.01). The concordance between the DNA chip and LA tests was 89.5{\%}, confirming substantial agreement (κ coefficient = 0.73), and the concordance between HC II and the DNA chip was 80.3{\%}, also showing substantial agreement (κ coefficient = 0.738). The concordance for 15 high-risk HPV genotypes between LA and sequencing was 82.5{\%} with a κ value of 0.536. Furthermore, the LA test was more sensitive in the detection of high-grade cervical lesions than HC II (100{\%} vs 92.3{\%}, P < 0.01). The LA test showed superior sensitivity in the detection of clinically relevant HPV infections and has proven to be an accurate tool for identifying individual HPV types, especially in cases of multiple HPV infections.",
author = "Lee, {Jae Kwan} and Kim, {Mi Kyung} and Song, {Seung Hun} and Hong, {Jin Hwa} and Min, {Kyung Jin} and Jae-Hoon Kim and Song, {Eun Seop} and Jungpil Lee and Lee, {Jong Min} and Hur, {Soo Young}",
year = "2009",
month = "2",
day = "1",
doi = "10.1111/IGC.0b013e31819bcd0a",
language = "English",
volume = "19",
pages = "266--272",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Comparison of human papillomavirus detection and typing by Hybrid Capture 2, Linear array, DNA chip, and cycle sequencing in cervical swab samples. / Lee, Jae Kwan; Kim, Mi Kyung; Song, Seung Hun; Hong, Jin Hwa; Min, Kyung Jin; Kim, Jae-Hoon; Song, Eun Seop; Lee, Jungpil; Lee, Jong Min; Hur, Soo Young.

In: International Journal of Gynecological Cancer, Vol. 19, No. 2, 01.02.2009, p. 266-272.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of human papillomavirus detection and typing by Hybrid Capture 2, Linear array, DNA chip, and cycle sequencing in cervical swab samples

AU - Lee, Jae Kwan

AU - Kim, Mi Kyung

AU - Song, Seung Hun

AU - Hong, Jin Hwa

AU - Min, Kyung Jin

AU - Kim, Jae-Hoon

AU - Song, Eun Seop

AU - Lee, Jungpil

AU - Lee, Jong Min

AU - Hur, Soo Young

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Although the Hybrid Capture II (HC II) assay can detect 13 high-risk human papillomavirus (HPVs), it does not yield any genotype-specific information. We evaluated the performance of 4 HPV DNA tests, namely, HC II, Linear Array (LA), DNA chip, and cycle sequencing for their capacity to detect the presence of high-risk HPV DNA and HPV-associated cervical lesions. Seventy-six women who were referred to the colposcopy clinic for abnormal cytology were enrolled. The women were examined using liquid-based cytology, colposcopy-directed biopsy, and HPV DNA tests. After DNA extraction from a single sample, HPV DNA tests were performed by all 4 methods on the same specimen. The LA test has higher HPV-positive rates than HC II for cervical intraepithelial neoplasia I (83.3% vs 61.1%; P < 0.01) and for cervical intraepithelial neoplasia II and more severe lesions (100.0% vs 80.0%; P < 0.01). The concordance between the DNA chip and LA tests was 89.5%, confirming substantial agreement (κ coefficient = 0.73), and the concordance between HC II and the DNA chip was 80.3%, also showing substantial agreement (κ coefficient = 0.738). The concordance for 15 high-risk HPV genotypes between LA and sequencing was 82.5% with a κ value of 0.536. Furthermore, the LA test was more sensitive in the detection of high-grade cervical lesions than HC II (100% vs 92.3%, P < 0.01). The LA test showed superior sensitivity in the detection of clinically relevant HPV infections and has proven to be an accurate tool for identifying individual HPV types, especially in cases of multiple HPV infections.

AB - Although the Hybrid Capture II (HC II) assay can detect 13 high-risk human papillomavirus (HPVs), it does not yield any genotype-specific information. We evaluated the performance of 4 HPV DNA tests, namely, HC II, Linear Array (LA), DNA chip, and cycle sequencing for their capacity to detect the presence of high-risk HPV DNA and HPV-associated cervical lesions. Seventy-six women who were referred to the colposcopy clinic for abnormal cytology were enrolled. The women were examined using liquid-based cytology, colposcopy-directed biopsy, and HPV DNA tests. After DNA extraction from a single sample, HPV DNA tests were performed by all 4 methods on the same specimen. The LA test has higher HPV-positive rates than HC II for cervical intraepithelial neoplasia I (83.3% vs 61.1%; P < 0.01) and for cervical intraepithelial neoplasia II and more severe lesions (100.0% vs 80.0%; P < 0.01). The concordance between the DNA chip and LA tests was 89.5%, confirming substantial agreement (κ coefficient = 0.73), and the concordance between HC II and the DNA chip was 80.3%, also showing substantial agreement (κ coefficient = 0.738). The concordance for 15 high-risk HPV genotypes between LA and sequencing was 82.5% with a κ value of 0.536. Furthermore, the LA test was more sensitive in the detection of high-grade cervical lesions than HC II (100% vs 92.3%, P < 0.01). The LA test showed superior sensitivity in the detection of clinically relevant HPV infections and has proven to be an accurate tool for identifying individual HPV types, especially in cases of multiple HPV infections.

UR - http://www.scopus.com/inward/record.url?scp=65649113260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649113260&partnerID=8YFLogxK

U2 - 10.1111/IGC.0b013e31819bcd0a

DO - 10.1111/IGC.0b013e31819bcd0a

M3 - Article

C2 - 19396007

AN - SCOPUS:65649113260

VL - 19

SP - 266

EP - 272

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 2

ER -